Cited in boardrooms, legal proceedings & government briefings since 2017
Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. However, regulations are constantly shifting.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. However, regulations are constantly shifting. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.
PDF + data
delivery format
2021
published
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.
